6P2A | pdb_00006p2a

Chimera of bacteriophage OBP gp146 central spike protein and a T4 gp5 beta-helix fragment

External Resource: Annotation

Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, B, C, D, E A, B, C, D, E, F	PF06715	Gp5 C-terminal repeat (3 copies) (Gp5_C)	Gp5 C-terminal repeat (3 copies)	-	Repeat

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B, C, D, E A, B, C, D, E, F	CHIMERA OF BACTERIOPHAGE OBP GP146 AND A T4 GP5	hydrolase activity, acting on glycosyl bonds peptidoglycan muralytic activity hydrolase activity, hydrolyzing O-glycosyl compounds lysozyme activity hydrolase activity catalytic activity identical protein binding protein binding binding	biological process involved in interspecies interaction between organisms symbiont entry into host biological process involved in interaction with host biological process involved in symbiotic interaction symbiont-mediated disruption of host anatomical structure viral life cycle symbiont-mediated disruption of host cell wall symbiont-mediated disruption of host cell envelope symbiont-mediated disruption of host cellular anatomical structure symbiont entry into host cell via disruption of host cell wall peptidoglycan symbiont entry into host cell viral process disruption of anatomical structure in another organism symbiont entry into host cell via disruption of host cell envelope biological process involved in interspecies interaction between organisms symbiont entry into host biological process involved in interaction with host biological process involved in symbiotic interaction symbiont-mediated disruption of host anatomical structure viral life cycle symbiont-mediated disruption of host cell wall symbiont-mediated disruption of host cell envelope symbiont-mediated disruption of host cellular anatomical structure symbiont entry into host cell via disruption of host cell wall peptidoglycan symbiont entry into host cell viral process disruption of anatomical structure in another organism symbiont entry into host cell via disruption of host cell envelope virion assembly viral tail assembly catabolic process cell wall organization or biogenesis metabolic process cellular process macromolecule metabolic process macromolecule catabolic process cell wall macromolecule catabolic process cell wall macromolecule metabolic process disruption of cell in another organism killing of cells of another organism cell killing defense response to bacterium response to stimulus response to other organism defense response response to bacterium response to stress response to external stimulus response to external biotic stimulus response to biotic stimulus carbohydrate derivative catabolic process peptidoglycan catabolic process glycosaminoglycan metabolic process carbohydrate derivative metabolic process aminoglycan catabolic process glycosaminoglycan catabolic process aminoglycan metabolic process peptidoglycan metabolic process	virus tail virion component virus tail, baseplate

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B, C, D, E A, B, C, D, E, F	IPR052619	Bacteriophage lysozyme-like	Family
A, B, C, D, E A, B, C, D, E, F	IPR009590	Protein Gp5, N-terminal OB-fold domain	Domain
A, B, C, D, E A, B, C, D, E, F	IPR023347	Lysozyme domain superfamily	Homologous Superfamily
A, B, C, D, E A, B, C, D, E, F	IPR023346	Lysozyme-like domain superfamily	Homologous Superfamily
A, B, C, D, E A, B, C, D, E, F	IPR046397	Pre-baseplate central spike protein Gp5	Family
A, B, C, D, E A, B, C, D, E, F	IPR001165	T4-type lysozyme	Family
A, B, C, D, E A, B, C, D, E, F	IPR010609	Gp5, C-terminal	Repeat
A, B, C, D, E A, B, C, D, E, F	IPR002196	Glycoside hydrolase, family 24	Family

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.